1204312-39-9

Basic information

• Product Name: 2-acetaMido-4-chloro-5-Methylbenzoic acid
• Synonyms: 2-acetaMido-4-chloro-5-Methylbenzoic acid;2-(acetylamino)-4-chloro-5-methylbenzoic acid
• CAS NO: 1204312-39-9
• Molecular Formula: C₁₀H₁₀ClNO₃
• Molecular Weight: 227.6443
• Mol File: 1204312-39-9.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 432.9±45.0 °C(Predicted)
• Appearance: /
• Density: 1.394±0.06 g/cm3(Predicted)
• PKA: 3.33±0.10(Predicted)
• CAS DataBase Reference: 2-acetaMido-4-chloro-5-Methylbenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-acetaMido-4-chloro-5-Methylbenzoic acid(1204312-39-9)
• EPA Substance Registry System: 2-acetaMido-4-chloro-5-Methylbenzoic acid(1204312-39-9)

Safety Data

• Hazardous Substances Data: 1204312-39-9(Hazardous Substances Data)

Usage

General Description

2-Acetamido-4-chloro-5-methylbenzoic acid is a chemical compound with the molecular formula C10H10N1O3Cl1. It is a derivative of acetylsalicylic acid, and it is used in the pharmaceutical industry as an intermediate for the synthesis of various drugs. 2-acetaMido-4-chloro-5-Methylbenzoic acid has both acetyl and amino groups attached to a benzene ring, as well as a chlorine and a methyl group. It is typically used as a building block in the synthesis of other pharmaceutical compounds and may also have potential therapeutic properties due to its structure. The exact uses and properties of 2-acetamido-4-chloro-5-methylbenzoic acid may vary depending on the specific application.

Upstream product

• 201230-82-2 carbon monoxide 
• 7149-79-3 N-(3-chloro-4-methylphenyl)acetamide 
• 124-38-9 carbon dioxide 
• 116010-06-1 N-(2-bromo-5-chloro-4-methylphenyl)acetamide 
• 95-74-9 3-chloro-p-toluidine 

Downstream Products

• 155184-81-9 2-amino-5-methyl-4-chlorobenzoic acid 

Relevant articles and documents

BENZAMIDE DERIVATIVE

The present invention relates to benzamide derivatives represented by formula (I) or pharmaceutically acceptable salts thereof.

Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3 H -quinazolin-6-yl)methylprop-2- ynylamino]- N -(3-pyridylmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt)

We have shown previously that the target of the potent cytotoxic agent 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino] -N-(3-pyridylmethyl)benzamide (CB38065, 1) is nicotinamide phosphoribosyltransferase (Nampt). With its cellular target known we sought to optimize the biochemical and cellular Nampt activity of 1 as well as its cytotoxicity. It was found that a 3-pyridylmethylamide substituent in the A region was critical to cellular Nampt activity and cytotoxicity, although other aromatic substitution did yield compounds with submicromolar enzymatic inhibition. Small unsaturated groups worked best in the D-region of the molecule, with 3,3-dimethylallyl providing optimal potency. The E region required a quinazolin-4-one or 1,2,3-benzotriazin-4-one group for activity, and many substituents were tolerated at C2 of the quinazolin-4-one. The best compounds showed subnanomolar inhibition of Nampt and low nanomolar cytotoxicity in cellular assays.